Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke

NCT00639249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: placebo
DRUG: SA4503 Low
DRUG: SA4503 High

Sponsor

M's Science Corporation